Tweet
<img alt="" height="1" width="1" />
Roche's Avastin helps slow ovarian cancer progression
Reuters
ZURICH, July 2 (Reuters) - Roche Holding AG's (ROG.VX) cancer drug Avastin, in combination with chemotherapy, helps women with ovarian cancer live for longer without their disease worsening, a second late-stage study has shown. ...
Roche's Avastin Helps Ovarian Cancer Patients Live LongerWall Street Journal
Avastin Proven To Slow Progression Of Ovarian CancerdBTechno
Second Phase III Ovarian Cancer Trial Finds Avastin-Chemotherapy Combo Boosts PFSGenetic Engineering News
CanadianBusiness.com -Automated Trader -MarketWatch (press release)
all 42 news articles »
More...